急性缺血性脑卒中合并糖尿病人群的血糖变异性与神经功能恶化的相关性分析

doi:10.3969/j.issn.1006-7795.2023.01.012

首都医科大学学报 ›› 2023, Vol. 44 ›› Issue (1): 78-84.doi: 10.3969/j.issn.1006-7795.2023.01.012

• 脑血管病的基础与临床研究 • 上一篇下一篇

急性缺血性脑卒中合并糖尿病人群的血糖变异性与神经功能恶化的相关性分析

李森^1,2, 郭学文³, 赵鑫⁴, 黄安琪⁴, 林婧格¹, 李兴茂^1,2, 李秀^1,2, 杜怡峰⁵, 赵咏梅⁶, 白洁^1*, 夏章勇^4*

1.聊城市人民医院内分泌科,山东第一医科大学附属聊城医院内分泌科,山东聊城 252000;
2.潍坊医学院临床医学院,山东潍坊 261053;
3.聊城市东昌府人民医院神经内科,聊城市人民医院东昌府院区神经内科,山东聊城 252000;
4.聊城市人民医院神经内科,山东第一医科大学附属聊城医院神经内科,山东聊城 252000;
5.山东第一医科大学附属省立医院神经内科,济南 250021;
6.首都医科大学宣武医院脑血管病研究所,北京 100053

收稿日期:2022-11-01 出版日期:2023-02-21 发布日期:2023-01-13
基金资助:
山东省自然科学基金(ZR2017PH054), 山东省中医药科技发展计划(2019-0887)。

Correlation between glycemic variability and neurological deterioration in patients with acute ischemic stroke and diabetes mellitus

Li Sen^1,2, Guo Xuewen³, Zhao Xin⁴, Huang Anqi⁴, Lin Jingge¹, Li Xingmao^1,2, Li Xiu^1,2, Du Yifeng⁵, Zhao Yongmei⁶, Bai Jie^1*, Xia Zhangyong^4*

1. Department of Endocrinology, Liaocheng People's Hospital, Liaocheng Hospital Affiliated to Shandong First Medical University, Liaocheng 252000,Shandong Province,China;
2. School of Clinical Medicine, Weifang Medical University, Weifang 261053,Shandong Province,China;
3. Department of Neurology, Dongchangfu People's Hospital, Liaocheng 252000,Shandong Province,China;
4. Department of Neurology, Liaocheng People's Hospital, Liaocheng Hospital Affiliated to Shandong First Medical University, Liaocheng 252000,Shandong Province,China;
5. Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021,China;
6. Institute of Cerebrovascular Disease Research, Xuanwu Hospital of Capital Medical University, Beijing 100053,China

Received:2022-11-01 Online:2023-02-21 Published:2023-01-13
Contact: *E-mail: yh2004920@163.com; lcdiabetes@sina.com
Supported by:
Natural Science Foundation of Shandong Province(ZR2017PH054),Shandong Traditional Chinese Medicine Science and Technology Development Project(2019-0887).

摘要/Abstract

摘要： 目的探索急性缺血性脑卒中(acute ischemic stroke, AIS)合并糖尿病人群的血糖变异性与神经功能损害的相关性。方法选取AIS合并糖尿病患者125例,记录基线状态下一般临床资料,并分别于入院及出院时进行美国国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NIHSS)评分,于出院1个月后随访进行改良Rankin量表(modified Rankin Scale,mRS)评分,评估患者卒中后神经功能变化与残障情况。根据NIHSS评分是否上升分为非恶化组(79例)和恶化组(46例),对比两组基线资料和血糖变异性参数。采用Logistic回归分析影响神经功能恶化的可能因素,并绘制受试者工作特征(receiver operating characteristic, ROC)曲线评估血糖变异性指标对神经功能恶化的预测价值。结果两组基线临床资料相比差异无统计学意义,两组血糖变异性参数相比,葡萄糖目标范围内时间(time in range,TIR)、平均血糖波动幅度(mean amplitude of glycemic excursions,MAGE)、最大血糖波动幅度(largest amplitude of glycemic excursions,LAGE)差异均存在统计学意义(P <0.05)。二元Logistic回归分析显示,TIR(OR=0.937, P<0.001)、MAGE(OR=1.360, P=0.024)、LAGE(OR=1.364, P=0.015)是NIHSS评分恶化的危险因素。有序多因素Logistic回归分析提示,入院48 h血糖平均值(OR=1.208, P=0.033)、MAGE(OR=1.206, P=0.040)以及入院空腹血糖(OR=1.182, P=0.016)是影响mRS评分的危险因素。ROC曲线提示TIR预测发生恶化的曲线下面积(area under the curve,AUC)为0.781(95%CI:0.699－0.862,P<0.001),灵敏度为82.6%,特异度为60.8%,最佳截断值为41.3%。结论以TIR等为代表的血糖变异性指标可能是提示AIS合并糖尿病患者神经功能恶化的相关因素。

关键词: 血糖变异性, 急性缺血性脑卒中, 糖尿病, 目标范围内时间

Abstract: Objective To explore the correlation between glycemic variability and neurological impairment in patients with acute ischemic stroke (AIS) complicated with diabetes mellitus. Methods A total of 125 patients with AIS and diabetes mellitus were selected. The general clinical data at baseline were recorded, and the National Institutes of Health Stroke Scale (NIHSS) was scored at admission and discharge respectively, and the modified Rankin Scale (mRS) score was recorded 1 month after discharge to evaluate neurological changes and disability after stroke. According to whether the NIHSS score worsened or not, the patients were divided into a non-deterioration group and a deterioration group, and the baseline data and glycemic variability parameters were compared between the two groups. Logistic regression was used to analyze the possible factors affecting neurological deterioration, and the receiver operating characteristic (ROC) curve was drawn to evaluate the predictive value of blood glucose variability indicators for neurological deterioration. Results There was no statistical difference in baseline clinical data between the two groups, but a statistical differences in blood glucose variability parameters with mean amplitude of glycemic excursions(MAGE) and largest amplitude of glycemic excursions(LAGE) (P<0.05). Binary Logistic regression analysis showed that time in range(TIR) (OR=0.937, P<0.001), MAGE (OR =1.360, P=0.024), and LAGE (OR=1.364, P=0.015) were the risk factors for worsening NIHSS score. Ordinal multivariate Logistic regression analysis showed that MEAN (OR=1.208, P=0.033), MAGE (OR=1.206, P=0.040) and admission fasting blood glucose (OR=1.182, P=0.016) were the risk factors affecting the mRS score. The ROC curve showed that the area under the curve (AUC) of TIR for predicting deterioration was 0.781 (95% CI:0.699－0.862, P<0.001), the sensitivity was 82.6%, the specificity was 60.8%, and the best cut-off value was 41.3%. Conclusion The glycemic variability indicators represented by TIR and others are related factors that may indicate the deterioration of neurological function in patients with AIS and diabetes mellitus.

Key words: glycemic variability, acute ischemic stroke, diabetes, time in range(TIR)

中图分类号:

R743.3

李森, 郭学文, 赵鑫, 黄安琪, 林婧格, 李兴茂, 李秀, 杜怡峰, 赵咏梅, 白洁, 夏章勇. 急性缺血性脑卒中合并糖尿病人群的血糖变异性与神经功能恶化的相关性分析[J]. 首都医科大学学报, 2023, 44(1): 78-84.

Li Sen, Guo Xuewen, Zhao Xin, Huang Anqi, Lin Jingge, Li Xingmao, Li Xiu, Du Yifeng, Zhao Yongmei, Bai Jie, Xia Zhangyong. Correlation between glycemic variability and neurological deterioration in patients with acute ischemic stroke and diabetes mellitus[J]. Journal of Capital Medical University, 2023, 44(1): 78-84.

参考文献

[1] Wu S M, Wu B, Liu M, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management[J]. Lancet Neurol, 2019, 18(4): 394-405.
[2] Bragg F, Holmes M V, Iona A, et al. Association between diabetes and cause-specific mortality in rural and urban areas of China[J]. JAMA, 2017, 317(3): 280-289.
[3] Wang Y J, Meng X, Wang A X, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA[J]. N Engl J Med, 2021, 385(27): 2520-2530.
[4] 彭斌, 吴波. 中国急性缺血性脑卒中诊治指南2018[J]. 中华神经科杂志, 2018, 51(9): 666-682.
[5] Li W, Maloney R E, Aw T Y. High glucose, glucose fluctuation and carbonyl stress enhance brain microvascular endothelial barrier dysfunction: implications for diabetic cerebral microvasculature[J]. Redox Biol, 2015, 5: 80-90.
[6] Ma Q F, Li R, Wang L J, et al. Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: an analysis for the Global Burden of Disease Study 2019[J]. Lancet Public Health, 2021, 6(12): e897-e906.
[7] Fuentes B, Pastor-Yborra S, Gutiérrez-Zúñiga R, et al. Glycemic variability: prognostic impact on acute ischemic stroke and the impact of corrective treatment for hyperglycemia. The GLIAS-Ⅲ translational study[J]. J Transl Med, 2020, 18(1): 414.
[8] Alfieri V, Myasoedova V A, Vinci M C, et al. The role of glycemic variability in cardiovascular disorders[J]. Int J Mol Sci, 2021, 22(16): 8393.
[9] Saisho Y. Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?[J]. Int J Mol Sci, 2014, 15(10): 18381-18406.
[10] Urner S, Ho F, Jha J C, et al. NADPH oxidase inhibition: preclinical and clinical studies in diabetic complications[J]. Antioxid Redox Signal, 2020, 33(6): 415-434.
[11] Baudu J, Gerbaud E, Catargi B, et al. High glycemic variability: an underestimated determinant of stroke functional outcome following large vessel occlusion[J]. Rev Neurol (Paris), 2022, 178(7): 732-740.
[12] Lee S H, Kim Y, Park S Y, et al. Pre-STROKE glycemic variability estimated by glycated albumin is associated with early neurological deterioration and poor functional outcome in prediabetic patients with acute ischemic stroke[J]. Cerebrovasc Dis, 2021, 50(1): 26-33.
[13] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中国实用内科杂志, 2018, 38(4): 292-344.
[14] Beck R W, Bergenstal R M, Cheng P Y, et al. The relationships between time in range, hyperglycemia metrics, and HbA1c[J]. J Diabetes Sci Technol, 2019, 13(4): 614-626.
[15] Battelino T, Danne T, Bergenstal R M, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range[J]. Diabetes Care, 2019, 42(8): 1593-1603.
[16] Danne T, Nimri R, Battelino T, et al. International consensus on use of continuous glucose monitoring[J]. Diabetes Care, 2017, 40(12): 1631-1640.
[17] Yoo J H, Kim J H. Time in range from continuous glucose monitoring: a novel metric for glycemic control[J]. Diabetes Metab J, 2020, 44(6): 828-839.
[18] Jiao X J, Shen Y F, Chen Y F. Better TIR, HbA1c, and less hypoglycemia in closed-loop insulin system in patients with type 1 diabetes: a meta-analysis[J]. BMJ Open Diabetes Res Care, 2022, 10(2): e002633.
[19] González-Moreno E I, Cámara-Lemarroy C R, González-González J G, et al. Glycemic variability and acute ischemic stroke: the missing link?[J]. Transl Stroke Res, 2014, 5(6): 638-646.
[20] Palaiodimou L, Lioutas V A, Lambadiari V, et al. Glycemic variability of acute stroke patients and clinical outcomes: a continuous glucose monitoring study[J]. Ther Adv Neurol Disord, 2021, 14: 17562864211045876.
[21] Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes[J]. JAMA, 2006, 295(14): 1681-1687.
[22] Hermanides J, Vriesendorp T M, Bosman R J, et al. Glucose variability is associated with intensive care unit mortality[J]. Crit Care Med, 2010, 38(3): 838-842.

急性缺血性脑卒中合并糖尿病人群的血糖变异性与神经功能恶化的相关性分析

Correlation between glycemic variability and neurological deterioration in patients with acute ischemic stroke and diabetes mellitus

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	姜富城, 黄菊梅, 冯跃先, 钟红亮, 贾建文, 杨洪超, 刘赫, 刘扬. 清醒镇静在急性缺血性脑卒中血管内治疗中的应用效果及预后影响评估[J]. 首都医科大学学报, 2023, 44(1): 72-77.
[2]	苏志燕, 刘薇, 史婷婷. 老年2型糖尿病患者血尿酸浓度与代谢综合征的相关性分析[J]. 首都医科大学学报, 2023, 44(1): 137-142.
[3]	黄琪, 周亦伦, 孙雪峰. 共享外周循环对糖尿病肾病小鼠肾损伤的影响[J]. 首都医科大学学报, 2022, 43(5): 674-679.
[4]	王梦迪, 郭弋凡, 庞彦余, 刘羽飞, 赵文景. 保肾通络方含药血清调节线粒体自噬对高糖诱导下足细胞氧化损伤的影响[J]. 首都医科大学学报, 2022, 43(5): 687-693.
[5]	于天宇, 姜世敏, 高红梅, 邹古明, 李文歌. 糖尿病肾病慢性肾脏病4期患者肾脏临床及病理因素与预后的关系[J]. 首都医科大学学报, 2022, 43(5): 707-712.
[6]	马艺欣, 张仲迎, 佀思聪, 罗鸿宇, 赵欢, 杨伟. 2型糖尿病患者新型脂肪因子血清内脏脂肪素和内脏脂肪特异性丝氨酸蛋白酶抑制因子的表达水平与左心室肥厚的关系[J]. 首都医科大学学报, 2022, 43(5): 767-773.
[7]	安宇, 边南南, 丁小雨, 常晓娜, 刘佳, 王广. 1型糖尿病伴认知功能损伤小鼠脑组织肠道菌群代谢物的改变[J]. 首都医科大学学报, 2022, 43(4): 622-629.
[8]	修双玲, 付俊玲, 穆志静, 孙丽娜, 赵蕾. 老年2型糖尿病患者体脂率对肌力和躯体功能的影响[J]. 首都医科大学学报, 2022, 43(4): 641-646.
[9]	宋丽敏, 李思源, 李军, 赵会荣, 李佳佳, 王双. 新疆石河子地区绝经后2型糖尿病女性SOST基因联合LRP5基因多态性及突变与骨代谢关系的研究[J]. 首都医科大学学报, 2022, 43(2): 269-274.
[10]	修双玲, 孙丽娜, 穆志静, 付俊玲, 赵蕾. 不同方法校正的肌肉质量与老年2型糖尿病躯体功能的相关性比较[J]. 首都医科大学学报, 2022, 43(2): 284-288.
[11]	杨柳青, 田红梅, 石汉平. 三种饮食模式与慢性疾病研究进展[J]. 首都医科大学学报, 2022, 43(2): 311-320.
[12]	张冬雪, 文祯, 孙玉燕, 姜涛. 初诊2型糖尿病患者中肝脏胰岛素清除率与临床特点及胃肠激素相关性的初步分析[J]. 首都医科大学学报, 2021, 42(5): 822-828.
[13]	李志, 张郡, 戴悦萱, 秦明阳, 梁芙茹. 血糖波动对2型糖尿病大鼠认知功能的影响[J]. 首都医科大学学报, 2021, 42(3): 347-353.
[14]	米颖馨, 王欣, 张开, 李可悦, 孙丽娜, 修双玲. 中老年男性2型糖尿病患者尿酸水平与肌少症的相关性研究[J]. 首都医科大学学报, 2021, 42(3): 453-458.
[15]	张冬雪, 林梅, 周璿, 刘文燕, 谷雅楠, 王左敏. 牙周状况对糖尿病肾病患者血糖控制的影响[J]. 首都医科大学学报, 2021, 42(2): 306-311.